Abstract
For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Current Genomics
Title: Defining Development Through Gene Expression Profiling
Volume: 3 Issue: 2
Author(s): Valerie Reinke
Affiliation:
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Abstract: For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Export Options
About this article
Cite this article as:
Reinke Valerie, Defining Development Through Gene Expression Profiling, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605215
DOI https://dx.doi.org/10.2174/1389202024605215 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Shcbp1 in Signaling and Disease
Current Cancer Drug Targets The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews Gene Therapy Strategies Towards Immune Tolerance to Treat the Autoimmune Diseases
Current Gene Therapy Advantages of Nanotechnology- Based Chinese Herb Drugs on Biological Activities
Current Drug Metabolism Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry Cell Type Specific Redox Status is Responsible for Diverse Electromagnetic Field Effects
Current Medicinal Chemistry Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors
Current Pharmaceutical Design Diabetes Gene Therapy: Potential and Challenges
Current Gene Therapy The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition Application of Stem Cell Therapy During the Treatment of HIV/AIDS and Duchenne Muscular Dystrophy
Current Stem Cell Research & Therapy Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Current Cancer Drug Targets Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy
Current Drug Delivery Radiation-Induced Extracranial Carotid Stenosis
Vascular Disease Prevention (Discontinued) Targeting Transcription Factors for Cancer Therapy
Current Pharmaceutical Design Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): Regulation of Apoptosis and Steroidogenesis as Part of the Host-Defense Response
Current Pharmaceutical Design Personalized Medicine for Glioblastoma: Current Challenges and Future Opportunities
Current Molecular Medicine MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology The Impact of Gynecological Cancer on Reproductive Issues and Pregnancy:Psychological Implications
Current Women`s Health Reviews Transient Abnormal Myelopoiesis in Down’s Syndrome - A Diagnostic Dilemma
Applied Clinical Research, Clinical Trials and Regulatory Affairs A Novel Mechanism for Metal-independent Hydroxyl Radical Production by Hydrogen Peroxide and Halogenated Quinones
Mini-Reviews in Organic Chemistry